MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$43,755K
Net Income
-$99,339K
Net Profit Margin
-227.03%
EPS
-$0.77
Unit: Thousand (K) dollars
Revenue Breakdown
Advanced Wound Care
Surgical And Sports Medicine
Grant
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
43,755
37,228
225,607
150,864
Cost of goods sold
23,673
25,772
73,641
36,251
Selling, general and administrative
53,965
65,186
100,174
79,743
Research and development
18,297
15,161
10,286
13,221
Write-down to fair value for asset held for sale
-
-
1,940
922
Fair value adjustment to assets held for sale
-1,188
-
-
-
Total operating expenses
94,747
106,119
186,041
130,137
Loss from operations
-50,992
-68,891
63,289
20,727
Interest income, net
-138
-380
-236
-415
Other income (expense), net
-26
38
-98
18
Total other income, net
112
418
138
433
Net loss before income taxes
-50,880
-68,473
63,427
21,160
Income tax benefit (expense)
45,387
-15,317
19,727
-407
Net loss and comprehensive loss
-96,267
-53,156
43,700
21,567
Accretion of redeemable convertible preferred stock to redemption value
170
159
150
140
Cumulative dividend on redeemable convertible preferred stock
2,902
2,844
2,788
2,734
Undistributed earnings allocated to participating redeemable convertible preferred stock
-
-
1,472
4,168
Net loss attributable to common stockholders, basic, total
-99,339
-56,159
39,290
14,525
Basic EPS
-0.77
-0.44
0.31
0.11
Diluted EPS
-0.77
-0.44
0.287
0.11
Basic Average Shares
128,674,548
127,797,013
126,921,657
126,881,709
Diluted Average Shares
128,674,548
127,797,013
136,995,475
130,848,995
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$99,339K
(-714.12%↓ Y/Y)
Net loss and
comprehensive loss
-$96,267K
(-924.99%↓ Y/Y)
Cumulative dividend on
redeemable convertible...
$2,902K
(8.24%↑ Y/Y)
Accretion of redeemable
convertible preferred stock...
$170K
(31.78%↑ Y/Y)
Interest income, net
-$138K
(79.37%↑ Y/Y)
Advanced Wound Care
$36,146K
Surgical And Sports
Medicine
$6,659K
Net loss before
income taxes
-$50,880K
(-329.95%↓ Y/Y)
Income tax benefit
(expense)
$45,387K
(1958.60%↑ Y/Y)
Total other income,
net
$112K
(-84.91%↓ Y/Y)
Product
$42,805K
(-57.53%↓ Y/Y)
Grant
$950K
(320.35%↑ Y/Y)
Other income
(expense), net
-$26K
(-135.62%↓ Y/Y)
Loss from operations
-$50,992K
(-305.47%↓ Y/Y)
Total revenue
$43,755K
(-56.68%↓ Y/Y)
Total operating
expenses
$94,747K
(-16.58%↓ Y/Y)
Fair value
adjustment to assets held...
-$1,188K
Selling, general and
administrative
$53,965K
(-26.89%↓ Y/Y)
Cost of goods sold
$23,673K
(-14.32%↓ Y/Y)
Research and development
$18,297K
(76.02%↑ Y/Y)
Buy us a coffee
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)